Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Technologies, Phenomenex

Premium
Agilent Technologies this week launched the High Sensitivity Protein 250 Kit for the company’s 2100 bioanalyzer. The kit is designed for pharmaceutical QA/QC and life science research applications and detects proteins down to as little as 1 picogram per microliter, which Agilent said is comparable to or better than silver-staining slab gels.
 
The kit features a dynamic range of four orders of magnitude for quantification and covers a sizing range of 10 to 250 kiloDaltons. Separation, quantitation, and purity measurements can be done in a single step, and typical throughput for QA/QC is 10 samples per hour, Agilent said in a statement. Each kit analyzes up to 100 samples.
 

 
Phenomenex introduced the 3 micrometer C18 300 Å HPLC column this week. The C18 reverse phase column is the most efficient of the company’s Jupiter line of products of protein characterization and purification, Phenomenex said in a statement, and provides better resolution and sharper peaks than other phases “enabling the separation of closely eluting proteins.”

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.